NuVasive, Inc. (NUVA) News
Filter NUVA News Items
NUVA News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
NUVA News Highlights
- For NUVA, its 30 day story count is now at 5.
- Over the past 8 days, the trend for NUVA's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- The most mentioned tickers in articles about NUVA are DOW, GMED and TOP.
Latest NUVA News From Around the Web
Below are the latest news stories about NUVASIVE INC that investors may wish to consider to help them evaluate NUVA as an investment opportunity.
Should You Investigate NuVasive, Inc. (NASDAQ:NUVA) At US$39.75?NuVasive, Inc. ( NASDAQ:NUVA ), is not the largest company out there, but it received a lot of attention from a... |
Globus Medical (GMED) Completes NuVasive Merger AgreementGlobus Medical's (GMED) recent deal combines complementary spine and orthopedic solutions, enabling technologies to create one of the industry's most comprehensive, innovative offerings. |
Why NuVasive (NUVA) is a Top Growth Stock for the Long-TermWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. |
NuVasive to Participate as Double Diamond Sponsor at Scoliosis Research Society Annual MeetingNuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will continue its partnership with the Scoliosis Research Society (SRS) as a double diamond sponsor and will attend the 58th Annual Meeting held September 6-9, 2023, in Seattle. |
Goosehead Insurance and Jackson Financial Set to Join S&P SmallCap 600S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600 effective prior to the opening of trading on Friday, September 1: |
NuVasive (NUVA) Q2 Earnings Meet Estimates, Margins DownNuVasive's (NUVA) second-quarter 2023 results reflect the robust performance of the U.S. Cervical business. |
NuVasive (NUVA) Q2 Earnings Meet EstimatesNuVasive (NUVA) delivered earnings and revenue surprises of 0% and 1.80%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock? |
NuVasive Announces Second Quarter 2023 Financial ResultsNuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter ended June 30, 2023. |
NuVasive Announces Conference Call and Webcast of Second Quarter 2023 ResultsNuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that it will release its second quarter 2023 results on Wednesday, August 2, 2023, after the close of the market. |
Here's Why You Should Retain Globus Medical (GMED) Stock NowInvestors continue to be optimistic about Globus Medical (GMED) based on the strong performances across geographies and the pending NuVasive acquisition. |